Basic Information
Forkhead BioTherapeutics was founded in 2017, leveraging endogenous cell fate conversion and regeneration to develop transformative therapies that improve patients' quality of life. In its early stages, the company focused on oral treatments for insulin-dependent diabetes.
Forkhead BioTherapeutics Inc
NewYork,NewYork,United States of America
less than 15 people
January 01, 2017
info@forkheadbio.com